Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04883671 · ClinicalTrials.gov registry record · NA

Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial

A NA study of Adenoid Cystic Carcinoma and Metastatic Adenoid Cystic Carcinoma, sponsored by Dana-Farber Cancer Institute.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
5
Study locations

NCT04883671 is a NA study of Adenoid Cystic Carcinoma and Metastatic Adenoid Cystic Carcinoma that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 32 participants, below the 126-participant average among 16 other Adenoid Cystic Carcinoma trials with a reported enrollment target (75% lower). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04883671, a NA study of Adenoid Cystic Carcinoma and Metastatic Adenoid Cystic Carcinoma, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
5
Study locations

Study Summary

The aim of this study is to learn whether the early initiation of a specialized and focused type of radiation called stereotactic body radiation therapy (SBRT) will impact the progression of advanced adenoid cystic carcinoma, quality of life, and overall survival. The name(s) of the study intervention involved in this study is: * Stereotactic Body Radiation Therapy (SBRT)

Conditions Studied

Adenoid Cystic Carcinoma Metastatic Adenoid Cystic Carcinoma

Interventions

  • OTHER Standard of Care
  • RADIATION SBRT

Study Locations (5)

Massachusetts

  • Brigham and Women's Hospital - Boston
  • Dana Farber Cancer Institute - Boston

California

  • University of California, San Francisco - San Francisco

Illinois

  • University of Chicago - Chicago

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2021-12-27
Est. Completion 2030-06-01
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04883671

The ClinicalTrials.gov registry entry for NCT04883671 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 126-participant average among 16 other Adenoid Cystic Carcinoma trials with a reported enrollment target (75% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Adenoid Cystic Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT04883671 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Massachusetts, California, Illinois.

Frequently Asked Questions

What is clinical trial NCT04883671 about?

NCT04883671 is a clinical study titled "Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial". The aim of this study is to learn whether the early initiation of a specialized and focused type of radiation called stereotactic body radiation therapy (SBRT) will impact the progression of advanced adenoid cystic carcinoma, quality of life, and overall survival. The name(s) of the study intervent...

What is the current status of trial NCT04883671?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2021-12-27. Estimated completion is 2030-06-01.

What conditions does trial NCT04883671 study?

This clinical trial studies the following conditions: Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma.

What interventions are being tested in trial NCT04883671?

The interventions under investigation include: Standard of Care (OTHER), SBRT (RADIATION).

Who is sponsoring clinical trial NCT04883671?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04883671 being conducted?

This trial has 5 study locations across California, Illinois, Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Adenoid Cystic Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Adenoid Cystic Carcinoma

All registered trials for this condition

Metastatic Adenoid Cystic Carcinoma

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.